日报更新时间：07-02 06:53
周报更新时间：01-16 11:49
今开价：71.91
最高价：72.01
成交量：35464.0
昨收价：71.82
最低价：71.88
最新价：71.955
中文名称：生物遥测
英文名称：BioTelemetry
行业：医疗
简介：Biotelemetry, Inc.是一家特拉华州的公司，前身为CardioNet公司
电话：1-610-7297000
BioTelemetry成立于25年前，致力于引领移动和无线医疗技术行业。公司专注于提供健康信息，以挽救和改善生活，同时降低护理成本。目前，公司为医疗保健和临床研究部门提供心脏和移动血糖监测，集中医疗成像和原始设备制造。生物遥测公司分为3个部门来运作：Healthcare（医疗保健），Research（研究），Corporate and Other（企业和其他）。 Healthcare——专注于远程心脏监测，以识别心律失常或心律紊乱。该部门提供移动心脏遥测服务; 和事件监控服务，使医生能够规定无线事件，数字循环事件，内存循环事件和非循环事件监视器。该部门还提供Holter和Extended-wear Holter监视器以及INR监视服务。该部门为为心脏病专家，电生理学家，神经科医生和初级保健医生提供服务。 Research——为药物和医疗器械试验提供实验室服务，如心脏监测，成像，科学咨询和数据管理服务。该部门主要服务包括心电图，动态心电图监测，动态血压监测，超声心动图，多门采集扫描，成像，协议开发，专家报告和统计分析。该部门还提供支持服务，例如项目协调，设置和管理，设备租赁，数据传输，处理，分析以及全天候客户支持和现场培训。 Corporate and Other——专注于为医疗保健公司制造，设计，开发和销售非侵入性心脏监护仪和其他人口健康管理设备，以及BioTel Care和BioTel Alliance品牌的合同制造服务。
| 交易日期 | 交易人 | 职位 | 类型 | 交易份额 | 价格 |
|---|---|---|---|---|---|
| 2019-05-05 | Hill Colin | Director | Sell | 25 | 52.87 |
| 2019-05-05 | Rimel (Rebecca W) | Director | Sell | 25 | 52.87 |
| 2019-05-02 | Gorman (Kirk E) | Director | Buy | 3592 | -- |
| 2019-05-02 | Gorman (Kirk E) | Director | Sell | 5518 | 53.69 |
| 2019-05-02 | Gorman (Kirk E) | Director | Buy | 5518 | 17.67 |
| 2019-05-02 | Hill Colin | Director | Buy | 2424 | -- |
| 2019-05-02 | Olson (Tiffany) | Director | Buy | 3007 | -- |
| 2019-05-02 | Frick (Joseph A) | Director | Buy | 3101 | -- |
| 2019-05-02 | Rietiker (Stephen) | Director | Buy | 2424 | -- |
| 2019-05-02 | Dietch (Laura N.) | Director | Buy | 2424 | -- |
| 2019-05-02 | Conti (Anthony James) | Director | Buy | 2424 | -- |
| 2019-05-02 | Rimel (Rebecca W) | Director | Buy | 2424 | -- |
| 2019-05-02 | Rubin Robert Joseph | Director | Buy | 3450 | -- |
| 2019-04-29 | Gorman (Kirk E) | Director | Sell | 5518 | 54.37 |
| 2019-04-29 | Gorman (Kirk E) | Director | Buy | 5518 | 17.67 |
| 2019-02-14 | Wisniewski (Daniel M) | Officer | Sell | 3695 | 77.59 |
| 2019-02-14 | Broadway (Fred Anthony III) | Officer | Sell | 3963 | 77.59 |
| 2019-02-14 | Getz (Heather C) | Chief Financial Officer | Sell | 5628 | 77.59 |
| 2019-02-14 | Ferola (Peter) | General Counsel | Sell | 3818 | 77.59 |
| 2019-02-14 | Capper (Joseph H) | Chief Executive Officer | Sell | 24359 | 77.59 |
| 2019-02-13 | Getz (Heather C) | Chief Financial Officer | Buy | 3946 | -- |
| 2019-02-13 | Ferola (Peter) | General Counsel | Buy | 1540 | -- |
| 2019-02-13 | Capper (Joseph H) | Chief Executive Officer | Buy | 10946 | -- |
| 2019-02-13 | Broadway (Fred Anthony III) | Officer | Buy | 1987 | -- |
| 2019-02-13 | Wisniewski (Daniel M) | Officer | Buy | 1553 | -- |
| 机构持股 | |||||
|---|---|---|---|---|---|
| 持有者 | 持有份额 | 持股比例 | 份额变化 | 变化率 | 报告日期 |
| Loomis Sayles & Company LP | 443935 | 1.31% | -23331 | -4.99% | 2019-03-31 |
| Hood River Capital Management LLC | 954906 | 2.82% | -36215 | -3.65% | 2019-03-31 |
| State Street Corporation | 1035104 | 3.06% | 7624 | 0.74% | 2019-03-31 |
| Credit Suisse Asset Management (Schweiz) AG | 1054341 | 3.11% | 150000 | 16.59% | 2019-07-31 |
| Dimensional Fund Advisors LP | 1105995 | 3.26% | -- | -- | 2019-07-31 |
| Dimensional Fund Advisors, Inc. | 1332585 | 3.94% | 1949 | 0.15% | 2019-03-31 |
| Vanguard Group Inc | 3502642 | 10.36% | 766297 | 28.00% | 2019-03-31 |
| BlackRock Fund Advisors | 3881310 | 11.45% | 20988 | 0.54% | 2019-07-31 |
| BlackRock Inc | 4968130 | 14.70% | -124643 | -2.45% | 2019-03-31 |
| Vanguard Investments Australia Ltd | 879885 | 2.60% | 168 | 0.02% | 2019-07-31 |
| Credit Suisse First Boston (CSFB) | 864087 | 2.56% | -59562 | -6.45% | 2019-03-31 |
| Macquarie Group Ltd | 761048 | 2.25% | -214535 | -21.99% | 2019-03-31 |
| Stephens Inv Mgmt Group LLC | 469359 | 1.39% | -1873 | -0.40% | 2019-03-31 |
| Northern Trust Corp | 469486 | 1.39% | 1807 | 0.39% | 2019-03-31 |
| Northern Trust Investments N A | 469486 | 1.39% | 1807 | 0.39% | 2019-03-31 |
| Carillon Tower Advisers, Inc. | 478632 | 1.42% | 354043 | 284.17% | 2019-03-31 |
| Eagle Asset Management, Inc. | 495890 | 1.47% | 495890 | -- | 2019-03-31 |
| Invesco Advisers, Inc. | 497458 | 1.47% | 18499 | 3.86% | 2019-07-31 |
| T. Rowe Price Associates, Inc. | 583314 | 1.73% | 30360 | 5.49% | 2019-03-31 |
| Northern Trust Investments Inc | 663301 | 1.96% | 6328 | 0.96% | 2019-07-31 |
| Amvescap Plc. | 1388364 | 4.11% | -260316 | -15.79% | 2018-12-31 |
| BlackRock Asset Management Canada Ltd | 4742690 | 14.03% | -21512 | -0.45% | 2019-05-31 |
| Bank of New York Mellon Corp | 773725 | 2.29% | 773725 | -- | 2018-12-31 |
| Geode Capital Management, LLC | 753236 | 2.23% | 416340 | 123.58% | 2018-12-31 |
| Delaware Management Company | 540120 | 1.60% | -208290 | -27.83% | 2019-05-31 |
| Mellon Investments Corporation | 492489 | 1.46% | 492489 | -- | 2018-12-31 |
| Ranger Investment Management LP | 484480 | 1.43% | -7548 | -1.53% | 2018-12-31 |
| Invesco Capital Management LLC | 471605 | 1.40% | -2466 | -0.52% | 2019-02-28 |
| Sterling Capital Management LLC | 556788 | 1.66% | -- | -- | 2018-09-30 |
| Rice Hall James & Associates, LLC | 450874 | 1.35% | -218202 | -32.61% | 2018-09-30 |
| Acadian Asset Management LLC | 621897 | 1.87% | 621897 | -- | 2018-06-30 |
| Invesco Advisers, Inc | 875947 | 2.63% | 188717 | 27.46% | 2018-09-30 |
| BlackRock Institutional Trust Company NA | 888694 | 2.67% | 18205 | 2.09% | 2018-06-30 |
| Delaware Management Business Trust | 1251683 | 3.76% | -28323 | -2.21% | 2018-09-30 |
| Glenmede Trust Co NA | 965134 | 2.90% | -110274 | -10.25% | 2018-06-30 |
| BNY Mellon Asset Management North America Corporation | 725089 | 2.18% | -296206 | -29.00% | 2018-06-30 |
| Wellington Management Company LLP | 795868 | 2.39% | -210178 | -20.89% | 2018-06-30 |
| Glenmede Investment Management, LP | 861767 | 2.59% | -132854 | -13.36% | 2018-11-30 |
| Pembroke Management Ltd | 476700 | 1.46% | -15300 | -3.11% | 2018-06-30 |
| Kennedy Capital Management Inc | 478161 | 1.46% | -121860 | -20.31% | 2018-06-30 |
| Invesco PowerShares Capital Mgmt LLC | 552865 | 1.69% | 368447 | 199.79% | 2018-06-30 |
| Mellon Capital Management Corporation | 725089 | 2.22% | -296206 | -29.00% | 2018-06-30 |
| State Street Corp | 986217 | 3.02% | 152570 | 18.30% | 2018-06-30 |
| Palisade Capital Management LLc | 392052 | 1.20% | 70188 | 21.81% | 2018-06-30 |
| Cannell Capital LLC | 343524 | 1.05% | 32793 | 10.55% | 2018-06-30 |
| Ziegler Capital Management LLC | 402438 | 1.23% | 33591 | 9.11% | 2018-03-31 |
| Arrowpoint Asset Management, LLC | 390064 | 1.19% | 390064 | -- | 2018-03-31 |
| Lyon Street Capital, LLC | 341077 | 1.04% | -37952 | -10.01% | 2018-03-31 |
| Summit Creek Advisors LLC | 380062 | 1.17% | 40366 | 11.88% | 2017-12-31 |
| Thompson, Siegel & Walmsley LLC | 538943 | 1.66% | 836 | 0.16% | 2017-12-31 |
| Renaissance Technologies Corp | 560500 | 1.73% | -392900 | -41.21% | 2017-12-31 |
| Hodges Capital Management Inc | 427940 | 1.32% | -12105 | -2.75% | 2017-09-30 |
| Allianz Global Investors | 417805 | 1.29% | -205077 | -32.92% | 2017-09-30 |
| CastleArk Management LLC | 437527 | 1.35% | 84580 | 23.96% | 2017-09-30 |
| Millennium Management LLC | 306358 | 0.95% | 306358 | -- | 2017-09-30 |
| Bank Of New York CO Inc. | 551025 | 1.92% | 551025 | -- | 2017-06-30 |
| AMG Fondsverwaltung AG | 290872 | 0.90% | 290872 | -- | 2017-10-31 |
| Cortina Asset Management LLC | 591109 | 2.09% | -17100 | -2.81% | 2016-09-30 |
| Royce & Associates, LLC | 476700 | 1.69% | -60000 | -11.18% | 2016-09-30 |
| Mckinley Capital Management LLC | 390773 | 1.38% | -77689 | -16.58% | 2016-09-30 |
| Wells Fargo Advisors, LLC | 376946 | 1.34% | -18156 | -4.60% | 2016-09-30 |
| Kalmar Investments Inc | 344803 | 1.22% | -44370 | -11.40% | 2016-09-30 |
| Golden Capital Management, LLC | 294055 | 1.04% | -39691 | -11.89% | 2016-09-30 |
| Bogle Investment Management L P | 273294 | 0.97% | 125827 | 85.33% | 2016-09-30 |
| 1492 Capital Management, LLC | 272846 | 0.97% | -12931 | -4.52% | 2016-09-30 |
| Thomson Horstmann&Bryant,Inc. | 1356249 | 3.00% | 13331928 | -- | 1999-11-30 |
| CorTina Asset ManagementLLC | 1359165 | 3.00% | 13360592 | -- | 1999-11-30 |
| Cannell CapitalLLC | 1454782 | 3.00% | 14300507 | -- | 1999-11-30 |
| BlackRockInc. | 1691601 | 3.00% | 16628438 | 0.10% | 1999-11-30 |
| 共同基金持股 | |||||
|---|---|---|---|---|---|
| 持有者 | 持有份额 | 持股比例 | 份额变化 | 变化率 | 报告日期 |
| Loomis Sayles Small Cap Growth Fund | 272257 | 0.80% | 13731 | 5.31% | 2019-06-30 |
| Vanguard Extended Market Index Fund | 463946 | 1.37% | -548 | -0.12% | 2019-06-30 |
| Vanguard Small Cap Growth Index Fund | 470393 | 1.39% | 1625 | 0.35% | 2019-06-30 |
| iShares S&P Small-Cap 600 Growth ETF | 492180 | 1.45% | -- | -- | 2019-07-30 |
| iShares Russell 2000 ETF | 737088 | 2.17% | 14447 | 2.00% | 2019-07-30 |
| Vanguard Small Cap Index | 828781 | 2.45% | 4730 | 0.57% | 2019-06-30 |
| Vanguard Total Stock Market Index Fund | 872397 | 2.57% | 211 | 0.02% | 2019-06-30 |
| Credit Suisse (Lux) Digital Health Eq Fd | 1042000 | 3.07% | 150000 | 16.82% | 2019-06-30 |
| iShares Core S&P Small-Cap ETF | 2043516 | 6.03% | 1969 | 0.10% | 2019-07-30 |
| DFA US Small Cap Portfolio | 443650 | 1.31% | -- | -- | 2019-05-31 |
| T. Rowe Price QM US Small-Cap Gr Eq Fd | 410300 | 1.21% | -- | -- | 2019-06-30 |
| Invesco Small Cap Growth Fund | 408334 | 1.20% | -- | -- | 2019-06-30 |
| JNL/Invesco Small Cap Growth Fund | 275686 | 0.81% | -3137 | -1.13% | 2019-03-31 |
| DFA US Micro Cap Portfolio | 301832 | 0.89% | -- | -- | 2019-05-31 |
| iShares Russell 2000 Growth ETF | 304386 | 0.90% | 5466 | 1.83% | 2019-07-30 |
| Vanguard Tax Managed Small Cap Fund | 324677 | 0.96% | 10600 | 3.37% | 2019-06-30 |
| Vanguard Explorer Fund | 325972 | 0.96% | 30284 | 10.24% | 2019-03-31 |
| Sterling Capital Stratton SmCp Val Fd | 351788 | 1.04% | -- | -- | 2019-06-30 |
| Carillon Eagle Small Cap Growth Fund | 355718 | 1.05% | -- | -- | 2019-06-30 |
| Ranger Small Cap Tr | 380436 | 1.12% | -4135 | -1.08% | 2019-06-30 |
| CS (Lux) Global Digital Health Equity Fd | 1042000 | 3.08% | 150000 | 16.82% | 2019-06-30 |
| Hood River Small-Cap Growth Fund | 264057 | 0.78% | 11265 | 4.46% | 2019-03-31 |
| Delaware Smid Cap Growth Fund | 535625 | 1.58% | -206250 | -27.80% | 2019-04-30 |
| iShares US Small Cap ETF (CAD-Hedged) | 672932 | 1.99% | -1134 | -0.17% | 2019-05-30 |
| iShares Core S&P US Total Market ETF | 2010485 | 5.95% | -- | -- | 2019-05-30 |
| iShares Core MSCI AllCntry Wld exCan ETF | 2010841 | 5.95% | -21242 | -1.05% | 2019-05-23 |
| Vanguard Small Cap Index Fund | 826426 | 2.44% | 6210 | 0.76% | 2019-04-30 |
| Invesco S&P SmallCap Health Care ETF | 284694 | 0.84% | -- | -- | 2019-03-31 |
| iShares US Medical Devices ETF | 279429 | 0.83% | 957 | 0.34% | 2019-02-28 |
| Robo Global | 189858 | 0.57% | -1024 | -0.54% | 2018-12-31 |
| Columbia Small Cap Index Fund | 185210 | 0.56% | -- | -- | 2018-11-30 |
| Innovator IBD | 198984 | 0.60% | -- | -- | 2018-12-28 |
| AMG Substanzwerte Schweiz | 232400 | 0.70% | -58472 | -20.10% | 2018-02-28 |
| Glenmede Small Cap Equity Portfolio | 861767 | 2.59% | -132854 | -13.36% | 2018-06-30 |
| iShares S&P Small-Cap 600 Growth | 543136 | 1.58% | 6885 | 1.28% | 2018-09-12 |
| Meridian Small Cap Growth Investor | 203382 | 0.62% | -5233 | -2.51% | 2018-06-30 |
| JNL/Invesco Small Cap Growth B | 214990 | 0.66% | 214990 | -- | 2018-06-30 |
| Principal SmallCap S&P 600 Idx SP | 194201 | 0.59% | 2976 | 1.56% | 2018-07-31 |
| SPDR | 183864 | 0.55% | 3328 | 1.84% | 2018-09-13 |
| Hood River Small Cap Growth Instl | 248843 | 0.76% | 25905 | 11.62% | 2018-06-30 |
| Vanguard Tax-Managed Small Cap Adm | 268477 | 0.82% | -- | -- | 2018-07-31 |
| Invesco Small Cap Growth A | 316217 | 0.97% | 316217 | -- | 2018-06-30 |
| Delaware Smid Cap Growth A | 1265825 | 3.87% | -- | -- | 2018-07-31 |
| Vanguard Total Stock Mkt Idx | 775047 | 2.37% | -- | -- | 2018-07-31 |
| Glenmede Small Cap Equity Adv | 861767 | 2.63% | -132854 | -13.36% | 2018-06-30 |
| Sterling Capital Stratton SmCp Val Instl | 556788 | 1.70% | -- | -- | 2018-08-31 |
| PowerShares S&P SmallCap Health Care ETF | 394268 | 1.17% | 8256 | 2.14% | 2018-09-13 |
| DFA US Small Cap I | 426762 | 1.30% | -- | -- | 2018-07-31 |
| Vanguard Extended Market Idx Inv | 411160 | 1.26% | 3736 | 0.92% | 2018-07-31 |
| iShares Russell 2000 Growth | 311254 | 0.90% | -300 | -0.10% | 2018-09-12 |
| Ranger Small-Cap Fund | 400309 | 1.22% | 400309 | -- | 2018-06-30 |
| DFA US Micro Cap I | 333593 | 1.02% | -- | -- | 2018-07-31 |
| iShares US Medical Devices | 294172 | 0.85% | 1090 | 0.37% | 2018-09-12 |
| T. Rowe Price QM US Small-Cap Growth Eq | 337400 | 1.03% | 38700 | 12.96% | 2018-06-30 |
| Columbia Small Cap Index Z | 169810 | 0.52% | 6610 | 4.05% | 2018-06-30 |
| Russell Small Cap Fund Class B | 169617 | 0.52% | -33436 | -16.47% | 2018-06-30 |
| Guggenheim S&P SmallCap 600 | 130928 | 0.44% | -- | -- | 2018-08-06 |
| Russell US Small Cap Equity I | 154637 | 0.47% | -16935 | -9.87% | 2018-06-30 |
| Fidelity Spartan | 138875 | 0.42% | 4997 | 3.73% | 2018-05-31 |
| Hodges Small Cap Retail | 170000 | 0.52% | -110000 | -39.29% | 2018-03-31 |
| ICON Healthcare S | 132595 | 0.41% | -27402 | -17.13% | 2018-02-28 |
| CREF Stock R1 | 149449 | 0.46% | 532 | 0.36% | 2018-02-28 |
| Royce Smaller-Companies Growth Svc | 143691 | 0.44% | -- | -- | 2017-12-31 |
| TETON Westwood Mighty Mites AAA | 143100 | 0.44% | -- | -- | 2017-09-30 |
| GE Instl Small-Cap Equity Inv | 162121 | 0.50% | 17211 | 11.88% | 2017-11-30 |
| Dreyfus Small Cap Stock Index | 109395 | 0.39% | -- | -- | 2016-12-31 |
| DFA Tax-Managed US Targeted Value | 104382 | 0.37% | -- | -- | 2016-12-31 |
| DFA US Core Equity 2 I | 102356 | 0.36% | -- | -- | 2016-12-31 |
| Icon Healthcare Fund | 332423 | 1.20% | 28100 | 9.20% | 2015-09-30 |
| DFA U.S. Micro Cap Portfolio | 260990 | 1.00% | 11887 | 4.80% | 2015-09-30 |
| DFA U.S. Small Cap Portfolio | 233339 | 0.90% | -- | -- | 2015-09-30 |
| Fidelity® Small Cap Growth Fund | 185287 | 0.70% | 185287 | -- | 2015-07-31 |
| Golden Small Cap Core Fund | 162428 | 0.60% | 25104 | 18.30% | 2015-09-30 |
| Kalmar Growth with Value Sm Cp Fd | 148185 | 0.50% | 71410 | 93.00% | 2015-09-30 |
| Bridgeway Ultra Small Company Market | 137700 | 0.50% | -- | -- | 2015-09-30 |
| Platinum International Healthcare | 130000 | 0.50% | -- | -- | 2015-09-30 |
| DFA US Small Cap Value II Portfolio | 117872 | 0.40% | -- | -- | 2015-09-30 |
| Gabelli Healthcare & Wellness Trust | 107800 | 0.40% | -2200 | -2.00% | 2015-06-30 |
| TETON Westwood Mighty Mites Fund | 107000 | 0.40% | -- | -- | 2015-06-30 |
| iShares Russell 2000 (AU) | 431599 | 1.50% | -546 | -0.10% | 2015-11-19 |
| Rebecca W. Rimel | Rebecca W. Rimel is President, Chief Executive Officer & Director at The Pew Charitable Trusts and on the board of 11 other companies. In the past Ms. Rimel was Assistant Professor at University of Virginia Health System and Executive Vice President of The Glenmede Trust Co., NA. Ms. Rimel received an MBA from James Madison University and an undergraduate degree from The University of Virginia School of Nursing. |
|---|---|
| Robert Joseph Rubin | Robert Joseph Rubin is on the board of Soligenix, Inc., Cardionet LLC, Cardiocore Lab LLC and BioTelemetry, Inc. and Professor at Georgetown University. In the past he occupied the position of President of Lewin-VHI, Inc., Principal at ICF, Inc., President at The Lewin Group, Inc., President at Lewin-ICF, Inc., Medical Director of Valuerx, Inc. and Assistant Secretary-Planning & Evaluation at US Department of Health & Human Services (DC). Robert Joseph Rubin received an undergraduate degree from Williams College and a doctorate from Weill Cornell Medical College. |
| Peter F. Ferola | Presently, Peter F. Ferola is Secretary, Senior Vice President & General Counsel at BioTelemetry, Inc. and Secretary, SVP-Development & General Counsel at Cardionet LLC and Secretary & Director at VirtualScopics, Inc. (both are subsidiaries of BioTelemetry, Inc.). In the past Mr. Ferola held the position of Corporate & Securities Attorney at Dilworth Paxson LLP, Corporate & Securities Attorney at Greenberg Traurig LLP and Secretary, Vice President & General Counsel for Trividia Health, Inc. Mr. Ferola received an undergraduate degree and a graduate degree from Nova Southeastern University, Inc. and a graduate degree from Georgetown University Law Center. |
| Anthony James Conti | Anthony James Conti occupies the position of Chairman of The Philadelphia Foundation. He is also on the board of 7 other companies. In his past career he occupied the position of Principal at Coopers & Lybrand LLP and Partner at PricewaterhouseCoopers LLP. Mr. Conti received an MBA from Temple University (Pennsylvania) and an undergraduate degree from St. Joseph's University. |
| Kirk E. Gorman | Kirk E. Gorman is a businessperson who has been the head of 6 different companies and currently occupies the position of Chairman of BioTelemetry, Inc. and Chairman for Cardiocore Lab LLC and Independent Chairman of Cardionet LLC (both are subsidiaries of BioTelemetry, Inc.). In the past Mr. Gorman was Chairman for Tiptree, Inc., President, Chief Financial Officer & Trustee at Universal Health Realty Income Trust, Chief Financial Officer & Senior Vice President at Universal Health Services, Inc., Chairman-Supervisory Board for LifeWatch GmbH, Senior Vice President for Mellon Bank, NA, Chief Financial Officer & Executive Vice President for Thomas Jefferson University and Chief Financial Officer & Executive Vice President of Jefferson Health System, Inc. Kirk E. Gorman received an undergraduate degree from Dartmouth College and an MBA from Tuck School of Business at Dartmouth. |
| Raymond Wayne Cohen | Founder of Axonics Modulation Technologies, Inc., Raymond Wayne Cohen is an American businessperson who has been the head of 14 different companies and currently holds the position of Chairman for LoneStar Heart, Inc., Non-Executive Chairman for Lombard Medical, Inc., Chairman for DySIS Medical Ltd., Chairman at BioLife Solutions, Inc., Chief Executive Officer & Director at Axonics Modulation Technologies, Inc. and Chairman for Syncroness, Inc. He is also on the board of Spectrum Pharmaceuticals, Inc., BioTelemetry, Inc. and BioGenex Laboratories, Inc. and Member of Forum for Corporate Directors. In the past Mr. Cohen was Chairman at JenaValve Technology, Inc. and Non-Executive Chairman at JenaValve Technology GmbH (a subsidiary of JenaValve Technology, Inc.), Chief Executive Officer & Director at The Irvine Co. LLC, Member-Biomedical Leadership Council at OCTANe, Chairman, President & Chief Executive Officer at Cardiac Science, Inc., Non-Executive Chairman at Lombard Medical Technologies Ltd., Chief Executive Officer & Director at Vessix Vascular, Inc., Director at CardioPolymers, Inc. and President at Diagnostic Monitoring. He received an undergraduate degree from State University of New York at Binghamton. |
| Joseph H. Capper | Joseph H. Capper is a businessperson who has been at the head of 7 different companies. Currently, Mr. Capper is President, Chief Executive Officer & Director at BioTelemetry, Inc. and Chairman-Management Board at LifeWatch GmbH (a subsidiary of BioTelemetry, Inc.). Mr. Capper is also on the board of Cardiocore Lab LLC and VirtualScopics, Inc. In the past Mr. Capper held the position of President & Chief Executive Officer at CCS Medical Holdings, Inc. President & Chief Executive Officer of CCS Medical, Inc. and President & Chief Executive Officer at Chronic Care Solutions, Inc. (both are subsidiaries of CCS Medical Holdings, Inc.), President, Chief Executive Officer & Director at Trividia Health, Inc., President, Chief Executive Officer & Director at Cardionet LLC, Director-National Sales at Bayer Corp. and Director-National Divisions Sales at Bayer Healthcare LLC. Mr. Capper received an undergraduate degree from West Chester University of Pennsylvania and an MBA from George Washington University. |
| Joseph A. Frick | Presently, Joseph A. Frick is Chairman at Philadelphia Works, Inc. and President for La Cruz Azul de Puerto Rico, Inc. He is also on the board of 10 other companies. In the past Mr. Frick occupied the position of Vice President-Human Resources of Philadelphia Newspapers LLC. Joseph A. Frick received an undergraduate degree from the University of Notre Dame and an MBA from Loyola University Maryland, Inc. |
| Tiffany P. Olson | Tiffany P. Olson is President-Nuclear & Precision Health Solutions at Cardinal Health, Inc. and on the board of 5 other companies. She previously occupied the position of President at NaviMed LLC, Owner at Resource Consulting Services, Vice President-Diagnostics at Eli Lilly & Co. and President, Chief Executive & Financial Officer at Roche Diagnostics Corp. She received an undergraduate degree from the University of Minnesota and an MBA from St. Thomas University (Florida). |
| Daniel M. Wisniewski | Daniel M. Wisniewski occupies the position of Senior Vice President-Technical Operations at BioTelemetry, Inc. and Senior Vice President-Business Operations at Cardionet LLC (a subsidiary of BioTelemetry, Inc.). Mr. Wisniewski is also Senior Vice President-Business Operations at Cardionet LLC. In the past he occupied the position of Chief Information Officer for CCS Medical Holdings, Inc. Chief Information Officer for CCS Medical, Inc. and Chief Information Officer of Chronic Care Solutions, Inc. (both are subsidiaries of CCS Medical Holdings, Inc.) and Vice President-Information Systems at Financial Information Technologies LLC. Mr. Wisniewski received an undergraduate degree from Virginia Military Institute. |
| Heather C. Getz | Currently, Heather C. Getz is Chief Financial Officer & Executive Vice President for BioTelemetry, Inc. and Chief Financial Officer & Head-Investor Relations of Cardionet LLC and Treasurer & Director at VirtualScopics, Inc. (both are subsidiaries of BioTelemetry, Inc.). In her past career she occupied the position of Vice President-Finance at Alita Pharmaceuticals, Inc., Principal at VIASYS Healthcare, Inc. and Principal at Sunoco, Inc. Ms. Getz received an undergraduate degree and an MBA from Villanova University. |
| Colin Hill | Colin Hill founded VIA Science, Inc., GNS Healthcare, Inc. and Fina Technologies, Inc. Mr. Hill occupies the position of Chairman of VIA Science, Inc., Chairman of O'Reilly Media, Inc. and Chairman & Chief Executive Officer at GNS Healthcare, Inc. Mr. Hill is also on the board of 5 other companies. In his past career Colin Hill occupied the position of Chairman of Fina Technologies, Inc. Mr. Hill received an undergraduate degree from Virginia Polytechnic Institute & State University, a graduate degree from McGill University and a graduate degree from Cornell University. |
| Daniel M. Wisniewski | Daniel M. Wisniewski occupies the position of Senior Vice President-Technical Operations at BioTelemetry, Inc. and Senior Vice President-Business Operations at Cardionet LLC (a subsidiary of BioTelemetry, Inc.). Mr. Wisniewski is also Senior Vice President-Business Operations at Cardionet LLC. In the past he occupied the position of Chief Information Officer for CCS Medical Holdings, Inc. Chief Information Officer for CCS Medical, Inc. and Chief Information Officer of Chronic Care Solutions, Inc. (both are subsidiaries of CCS Medical Holdings, Inc.) and Vice President-Information Systems at Financial Information Technologies LLC. Mr. Wisniewski received an undergraduate degree from Virginia Military Institute. |
| Fred Anthony Broadway | Fred Anthony Broadway occupies the position of Senior Vice President-Sales & Marketing of BioTelemetry, Inc. and Senior Vice President-Sales & Marketing for Cardionet LLC (a subsidiary of BioTelemetry, Inc.). In his past career Mr. Broadway occupied the position of Principal at Pfizer Inc., Principal at Sanofi Pharmaceuticals and Marketing Director at Bristol-Myers Squibb Co. He received an undergraduate degree from Auburn University. |
| Laura N. Dietch | Founder of BioTrace Medical, Inc., Laura N. Dietch is President, Chief Executive Officer & Director at this company. She is also on the board of Cardiocore Lab LLC and BioTelemetry, Inc. and Member of Life Science Angels, Inc. Ms. Dietch received an undergraduate degree from the University of Massachusetts and a graduate degree and an MBA from the University of California, Berkeley. |
| Stephan Rietiker | Stephan Rietiker is on the board of Cardiocore Lab LLC, LoneStar Heart, Inc. and BioTelemetry, Inc. In the past Dr. Rietiker occupied the position of Chief Executive Officer at LifeWatch GmbH and Chief Executive Officer of Centerpulse AG. He received a doctorate from the University of Zurich. |
| Wayne M. Derkac | Presently, Wayne M. Derkac holds the position of Senior Vice President-Medical Affairs at BioTelemetry, Inc. He previously held the position of President-Mid Atlantic Cardiothoracic Surgeons at Sentara Norfolk General Hospital and Associate at National Institutes of Health. Dr. Derkac received a doctorate from Columbia University College of Physicians & Surgeons. |
| Manish Wadhwa | Dr. Manish Wadhwa, MD, is a Chief Medical Officer at BioTelemetry, Inc. and a Chief Medical Officer & Director at Geneva Healthcare, Inc. He is on the Board of Directors at Geneva Healthcare, Inc. He received his undergraduate degree from The Pennsylvania State University and a doctorate degree from Thomas Jefferson University. |
| Tim Raher | Presently, Tim Raher is Senior Vice President-Human Resources for BioTelemetry, Inc. Mr. Raher previously occupied the position of Senior Vice President-Human Resources for LifeWatch Services, Inc. He received an undergraduate degree and an MBA from Lewis University and a graduate degree from Dallas Baptist University. |
abu_quant
扫一扫关注阿布量化
热门推荐
全部评论 2
【道指开盘涨0.04%，标普500涨0.1%，纳指涨0.3%】健康服务公司BioTelemetry涨17.9%，飞利浦宣布将斥资24.7亿美元收购该公司。DoorDash跌1.0%，香橼沽空Doordash，目标价40美元。理想汽车涨0.9%，理想汽车累计交付量突破30000辆，创下新造车势力首款车型最快交付纪录。
【美股盘前消息速报】①美国股指期货周五盘前小幅攀升，市场聚焦英国脱欧协议，及美国财政刺激法案。今晚将迎来美股今年最后一个“四巫日”，大型衍生工具头寸的滚动通常会加大市场波动。②截至发稿，道指期货涨0.02%，标指期货涨0.1%，纳指期货涨0.1%。③英国富时100指数和德国DAX指数分别上涨了0.48%和0.19%，法国CAC指数下跌了0.07%。④黄金回落至1880美元关口下方。鉴于美国国会对于刺激法案的协议还未达成，美元因近期的超卖环境得以反弹，从而令以美元计价的黄金承压。⑤日内几乎没有重要的经济数据公布，但两大协议成为焦点——即美国刺激法案和英欧退欧贸易协议。⑥区块链板块盘前普涨，嘉楠科技涨5.8%，Bit Digital涨5.2%，Marathon Patent涨4.7%，Riot Blockchain涨2.9%。⑦Moderna盘前跌1.39%。美国食品药品监督管理局（FDA）发言人：Moderna的新冠疫苗还没有获得授权，紧急使用授权（EUA）还在审核之中。⑧健康服务公司BioTelemetry盘前涨超15%，今日飞利浦宣布将斥资24.7亿美元收购该公司。⑨ 理想汽车盘前涨2.6%，理想汽车累计交付量突破30000辆，创下新造车势力首款车型最快交付纪录。